Medi Assist Healthcare Services Ltd Q2FY26 – The Health Insurance Whisperer Just Got Louder (But Profit Went on a Diet)
1. At a Glance
India’s biggest health-tech middleman — sorry, “Third-Party Administrator” — just dropped its Q2FY26 results, and the numbers scream “growth with hiccups.” Medi Assist Healthcare Services Ltd (NSE: MEDIASSIST), with a market cap of ₹4,139 crore and a stock price of ₹557, plays the crucial but unsung role of connecting insurance companies, hospitals, and policyholders in the chaos of health insurance claims.
In Q2FY26, revenue soared 28.6% YoY to ₹232.55 crore, but profit took a nosedive — down 62.1% YoY to ₹8.07 crore. Yeah, that’s the equivalent of running a marathon only to trip at the finish line. Operating margins, once a healthy 21–24%, dropped to 17%. The P/E stands at a rather doctor-like 50.9x — diagnosing “expensive” with a side of optimism.
Return on equity? 17.4%. Return on capital employed? 18.7%. Both respectable — unless you remember this company’s role is to handle other people’s money. The promoters now own a measly 4.87%, down from nearly 40% a year ago, after Bessemer packed its bags. Institutions, however, love this patient — holding almost 70% of the equity.
Revenue up, PAT down, shareholding shaken — Medi Assist is the classic corporate version of a gym bro: bulking up the top line while skipping leg day on profits.
2. Introduction
Medi Assist Healthcare Services Ltd is what happens when insurance and IT have a baby — and the baby grows up to handle ₹14,500 crore worth of health premiums annually. The company doesn’t insure anyone itself; instead, it acts as the referee ensuring hospitals and insurers don’t strangle each other over claims.
Founded in 2000, Medi Assist has evolved from a boring paperwork processor into a tech-heavy ecosystem player, bridging 35 insurance companies, over 9,500 corporate clients, and nearly 19,000 hospitals. They’re everywhere — from corporate health policies to government healthcare schemes.
It’s not glamorous work. Nobody ever thanks the TPA after getting a hospital claim settled — but if they mess up, everyone’s angry. Yet, in this unsexy corner of the insurance market, Medi Assist has quietly carved a monopoly-like niche with 26% share in India’s group health insurance market.
The IPO in January 2024 was a blockbuster — ₹1,172 crore raised via offer for sale. But post-listing, the stock pulled an “Ayushmann Khurrana movie”: strong debut, then reality kicked in. Profit dipped, promoter stake vanished, and an ED search in a subsidiary made headlines. Still, Medi Assist keeps hustling, acquiring competitors and building an AI-powered claims empire.
So, while your claim takes 7–10 business days, this company’s growth story is far from sick — it’s just going through post-listing puberty.
3. Business Model – WTF Do They Even Do?
Medi Assist is a Third Party Administrator (TPA) — basically the middleman who ensures your insurance company actually pays your hospital bill and doesn’t ghost you.
Here’s how it works:
You fall sick.
You land in a hospital (hopefully cashless).
The hospital sends your details to the insurer.
The insurer forwards them to Medi Assist.
Medi Assist checks the paperwork, approves the claim, and pays the hospital.
They make money by charging a fee per claim or as a percentage of premiums handled. Their client base includes insurance companies like Star Health, ICICI Lombard, and corporate giants that buy group insurance for employees.
Subsidiaries:
Medi Assist TPA (core engine, 89.87% of revenue)
Medvantage TPA and Raksha TPA (acquired units)
IHMS, Mayfair India/UK/Philippines, etc., offering call center and claims management services
Recent Expansion: In July 2025, Medi Assist’s subsidiary acquired Paramount TPA, adding ₹4,000 crore in premium processing power. That’s like swallowing your competitor’s lunch and then sending them the bill.
The company’s model thrives on scale, tech, and data analytics — the more claims they process, the more profitable (in theory) it becomes. But lately, margins are thinning like an overused hospital blanket.
4. Financials Overview
Let’s slice the Q2FY26 numbers like a surgeon with precision (figures in ₹ crore):
Metric
Latest Qtr (Sep’25)
YoY Qtr (Sep’24)
Prev Qtr (Jun’25)
YoY %
QoQ %
Revenue
232.55
180.77
190.56
28.6%
22.0%
EBITDA
39.71
38.45
42.01
3.3%
-5.5%
PAT
8.07
21.01
22.63
-61.6%
-64.3%
EPS (₹)
1.13
2.99
3.18
-62.2%
-64.5%
Annualised EPS = ₹1.13 × 4 = ₹4.52, which gives an implied P/E of 123x — not exactly cheap for a company that just lost 62% of its quarterly profit.
Commentary: The revenue story is strong — thanks to acquisitions and scaling, but profits? They’ve gone for a long walk. Depreciation and interest costs ballooned due to acquisitions (Paramount and others), squeezing the bottom line. It’s like eating more but burning fewer calories.
5. Valuation Discussion – Fair Value Range Only
Let’s diagnose Medi Assist’s fair value with three methods (figures in ₹ crore).
a) P/E Method:
TTM EPS = ₹11.55
Industry average P/E = 43.8
Current P/E = 50.9
Applying reasonable range (35x–45x): → Fair Value Range = ₹404 to ₹520 per share
b) EV/EBITDA Method:
EV = ₹4,316 cr
EBITDA (TTM) = ₹162 cr
EV/EBITDA = 26.6x
Industry comfort zone = 18x–22x → Fair EV/EBITDA Range = ₹2,900 – ₹3,600 cr → Per Share Fair Value ≈ ₹390 – ₹490
